<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url><loc>https://psiconautica.org/noticias/psilocibina-parkinson-marcadores-inflamatorios-piloto-sin-control/</loc><news:news><news:publication><news:name>Psiconáutica</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-10-29T11:42:08+01:00</news:publication_date><news:title>Psilocibina y párkinson: marcadores inflamatorios en sangre más bajos en 9 pacientes, sin grupo control</news:title></news:news><image:image><image:loc>https://psiconautica.org/wordpress/wp-content/uploads/2026/10/psico-daily-34263-scaled.jpg</image:loc></image:image></url>
  <url><loc>https://psiconautica.org/noticias/mebufotenina-intranasal-depresion-resistente-ensayo-fase-2b-jama/</loc><news:news><news:publication><news:name>Psiconáutica</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-10-29T11:42:05+01:00</news:publication_date><news:title>Mebufotenina intranasal en depresión resistente: ensayo fase 2b con 193 adultos</news:title></news:news><image:image><image:loc>https://psiconautica.org/wordpress/wp-content/uploads/2026/10/psico-daily-34259-scaled.jpg</image:loc></image:image></url>
</urlset>